Julie A Gayle
Overview
Explore the profile of Julie A Gayle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munjal I, Dreyfus J, Yu H, Begier E, Gurtman A, Gayle J, et al.
Infect Control Hosp Epidemiol
. 2022 Mar;
43(11):1625-1633.
PMID: 35272728
Objective: To determine the 180-day cumulative incidence of culture-confirmed infections after elective pediatric surgeries. Design: Retrospective cohort study utilizing the Premier Healthcare database (PHD). Setting: Inpatient and hospital-based outpatient elective...
2.
Moon R, Mackey R, Cao Z, Emont S, Schott L, Gayle J, et al.
Clin Infect Dis
. 2021 Sep;
74(12):2238-2242.
PMID: 34534276
After an initial decline from April through June 2020 (from 22.2% to 11.9%), adjusted in-hospital mortality in coronavirus disease 2019 (COVID-19) inpatients peaked twice and was significantly higher than June...
3.
Zheng Y, Kim R, Yu T, Gayle J, Wassel C, Dreyfus J, et al.
Oncologist
. 2021 Jul;
26(11):e2002-e2012.
PMID: 34327774
Background: With increased use of immune checkpoint inhibitors (ICIs) among patients with cancer, there is substantial interest in understanding clinical and economic outcomes and management of immune-related adverse events (irAEs)....
4.
Zheng Y, Yu T, Mackey R, Gayle J, Wassel C, Phatak H, et al.
Clinicoecon Outcomes Res
. 2021 Apr;
13:213-226.
PMID: 33790597
Purpose: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with poor prognosis. This study compared patient characteristics, comorbidities, adverse events (AEs), treatment persistence, healthcare resource utilization (HRU) and...
5.
Wassel C, Delhougne G, Gayle J, Dreyfus J, Larson B
Int Wound J
. 2020 Aug;
17(6):1924-1934.
PMID: 32830460
Pressure injuries are one of the most common and costly complications occurring in US hospitals. With up to 3 million patients affected each year, hospital-acquired pressure injuries (HAPIs) place a...
6.
Kaye A, Renschler J, Cramer K, Anyama B, Anyama E, Gayle J, et al.
Curr Pain Headache Rep
. 2019 Jun;
23(7):48.
PMID: 31147838
Purpose Of Review: Total patient care is of extreme importance during the administration of anesthesia. Proper care of the eye is necessary during all anesthetic administrations, especially during the administration...
7.
Kaye A, Urman R, Cornett E, Hart B, Chami A, Gayle J, et al.
J Anaesthesiol Clin Pharmacol
. 2019 May;
35(Suppl 1):S35-S39.
PMID: 31142957
The enhanced recovery after surgery (ERAS) concept, sometimes referred to as "fast track", "accelerated," or "Rapid Recovery" surgery, was first introduced in 1997. The concept of ERAS targets factors that...
8.
Coleman S, Chen M, Patel S, Yan H, Kaye A, Zebrower M, et al.
Curr Pain Headache Rep
. 2019 Mar;
23(4):28.
PMID: 30868281
Purpose Of Review: Enhanced recovery after surgery (ERAS) has become a widespread topic in perioperative medicine over the past 20 years. The goals of ERAS are to improve patient outcomes...
9.
Hadley G, Gayle J, Ripoll J, Jones M, Argoff C, Kaye R, et al.
Curr Pain Headache Rep
. 2016 Mar;
20(4):28.
PMID: 27002967
No abstract available.
10.
Hadley G, Gayle J, Ripoll J, Jones M, Argoff C, Kaye R, et al.
Curr Pain Headache Rep
. 2016 Feb;
20(3):17.
PMID: 26879875
Post-herpetic neuralgia (PHN) is a chronic neuropathic pain condition that persists 3 months or more following an outbreak of shingles. Shingles, also known as acute herpes zoster, is associated with...